Treatment mechanism of immune triad from the repurposing drug against COVID-19
COVID-19 is an immune-mediated disease whose pathophysiology uses SAMHD1 tetramerization and cGAS–STING signaling, toll-like receptor 4 (TLR4) cascade, spike protein– inflammasome activation, and neuropilin 1 (NRP1) signaling. Variants of concern, such as SARS-CoV-2 Omicron Subvariants BQ.1, BQ.1.1,...
Guardat en:
| Autor principal: | |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
KeAi Communications Co., Ltd.
2023-01-01
|
| Col·lecció: | Translational Medicine of Aging |
| Matèries: | |
| Accés en línia: | http://www.sciencedirect.com/science/article/pii/S2468501123000093 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|